ProKidney Corp. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ProKidney Corp. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $547.00K.
- ProKidney Corp. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $212.00K.
- ProKidney Corp. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $495.00K.
- ProKidney Corp. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $854.00K.
- ProKidney Corp. stock issued during period, value, stock options exercised for fiscal 2025 was $1.35M, a 870.50% increase from fiscal 2024.
- ProKidney Corp. stock issued during period, value, stock options exercised for fiscal 2024 was $139.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $547.00K 10-Q · filed 2026-08-10 | $2.11M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $212.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $495.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $1.35M 10-K · filed 2026-03-18 |
| 2025-09-30 | $854.00K 10-Q · filed 2025-11-10 | |
| 2024-12-31 | $139.00K 10-K · filed 2026-03-18 |